Sarilumab shows long-term promise in RA refractory to TNF inhibitorsJuly 27, 2021Rheumatoid Arthritis
RA: Systemic glucocorticoids most beneficial for pain reduction shortly after initiationJuly 27, 2021Rheumatoid Arthritis
Bazedoxifene effectively prevents glucocorticoid-induced bone loss in RAJuly 27, 2021Rheumatoid Arthritis
RA: No significant change in efficacy and safety after adalimumab to CT-P17 switchJuly 27, 2021Rheumatoid Arthritis
Rheumatology NewsAre you at legal risk for speaking at conferences?July 27, 2021Business of MedicineMixed Topics
Rheumatology NewsFormer rheumatologist settles civil fraud claims for $2 millionJuly 27, 2021Business of Medicine
Rheumatology NewsCOVID-19 vaccination does not increase risk of flare in patients with lupusJuly 27, 2021Lupus & Connective Tissue DiseasesCOVID-19 Updates
Risk for MACEs higher in new users of IL12/23 and IL17 inhibitors vs TNF inhibitors in PsAJuly 26, 2021Psoriatic Arthritis
bDMARDs may mitigate risk for psoriatic arthritis in chronic plaque psoriasisJuly 26, 2021Psoriatic Arthritis
PsA: Tofacitinib shows more rapid improvement in pain compared with placeboJuly 26, 2021Psoriatic Arthritis
Secukinumab: A potentially effective first-line biologic therapy for PsAJuly 26, 2021Psoriatic Arthritis
